These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8450290)

  • 1. Modified forms of low-density lipoprotein and atherosclerosis.
    Steinberg D
    J Intern Med; 1993 Mar; 233(3):227-32. PubMed ID: 8450290
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of oxidized low density lipoprotein in atherogenesis.
    Parthasarathy S; Rankin SM
    Prog Lipid Res; 1992; 31(2):127-43. PubMed ID: 1461917
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptors for oxidized low density lipoprotein.
    Steinbrecher UP
    Biochim Biophys Acta; 1999 Jan; 1436(3):279-98. PubMed ID: 9989260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
    Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
    Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins in atherosclerosis: from quantity to quality.
    Avogaro P; Cazzolato G; Bittolo Bon G; Zago S
    Prog Clin Biol Res; 1988; 255():1-6. PubMed ID: 3277194
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis.
    Esterbauer H; Schmidt R; Hayn M
    Adv Pharmacol; 1997; 38():425-56. PubMed ID: 8895819
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular biology: a cholesterol tether.
    Staels B
    Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages.
    Henson DA; St Clair RW; Lewis JC
    Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of multiply-modified (desialated) low-density lipoproteins, isolated from the blood of patients with atherosclerosis,with cellular receptors].
    Tertov VV; Sobenin IA; Nazarova VL; Gil'dieva BS; Via DP; Orekhov AP
    Biull Eksp Biol Med; 1994 Jan; 117(1):53-5. PubMed ID: 8193331
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein oxidation and atherosclerosis.
    Young IS; McEneny J
    Biochem Soc Trans; 2001 May; 29(Pt 2):358-62. PubMed ID: 11356183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis.
    Eisenberg S
    Am Heart J; 1987 Feb; 113(2 Pt 2):555-61. PubMed ID: 3544770
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure.
    Hasselwander O; Young IS
    Med Hypotheses; 1997 Nov; 49(5):389-95. PubMed ID: 9421803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins.
    Arai H; Kita T; Yokode M; Narumiya S; Kawai C
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1375-82. PubMed ID: 2930567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in the uptake and degradation of low density lipoprotein by the artery wall in vivo.
    Steinberg D; Pittman RC; Carew TE
    Ann N Y Acad Sci; 1985; 454():195-206. PubMed ID: 3907462
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of altered lipoproteins in the pathogenesis of atherosclerosis.
    Haberland ME; Fogelman AM
    Am Heart J; 1987 Feb; 113(2 Pt 2):573-7. PubMed ID: 3544773
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.